1

Flexible Biotech Equity Research Jobs (NOW HIRING)

Self-motivated, organized, has strong attention to detail and is willing to work within a flexible ... In addition, he has seven years of Biotech Equity Research experience covering a broad range of ...

Join Barclays as an Equity Research Biotech, AVP, where you'll have the chance to collaborate with the Senior Analyst to produce comprehensive research reports and presentations while monitoring ...

Minimum Required: 4 years of experience in biotech equity research or oncology focused healthcare ... flexible spending accounts, tuition & certification assistance programs, paid time off, and much ...

next page

Showing results 1-20

Flexible Biotech Equity Research information

See salary details

$34.5K

$98.8K

$155K

How much do flexible biotech equity research jobs pay per year?

As of Aug 24, 2026, the average yearly pay for flexible biotech equity research in the United States is $98,799.00, according to ZipRecruiter salary data. Most workers in this role earn between $91,000.00 and $112,000.00 per year, depending on experience, location, and employer.

What is the difference between Flexible Biotech Equity Research vs Biotech Equity Analyst?

AspectFlexible Biotech Equity ResearchBiotech Equity Analyst
CredentialsTypically requires finance or biotech background, CFA preferredSimilar credentials, often CFA or finance degree
Work EnvironmentFlexible hours, remote options, research-focusedOffice-based, client-facing, research and analysis
Industry UsageUsed in investment firms, hedge funds, research institutionsCommonly employed in asset management, investment banks

Flexible Biotech Equity Research and Biotech Equity Analyst roles share similar credentials and industry usage, focusing on biotech sector analysis. The key difference lies in flexibility; the former often offers remote work and adaptable hours, while the latter tends to be more structured and office-based. Both roles involve analyzing biotech companies to inform investment decisions, but Flexible Biotech Equity Research emphasizes adaptability in work arrangements.

More about Flexible Biotech Equity Research jobs

What cities are hiring for Flexible Biotech Equity Research jobs?

Cities with the most Flexible Biotech Equity Research job openings:

What are the most commonly searched types of Biotech Equity Research jobs?

The most popular types of Biotech Equity Research jobs are:

What states have the most Flexible Biotech Equity Research jobs?

States with the most job openings for Flexible Biotech Equity Research jobs include:

Infographic showing various Flexible Biotech Equity Research job openings in the United States as of August 2026, with employment types broken down into 1% As Needed, 69% Full Time, 27% Part Time, and 3% Contract. Highlights an 80% Physical, 1% Hybrid, and 19% Remote job distribution, with an average salary of $98,799 per year, or $47.5 per hour.

Equity Research Associate- Biotech

Roth Capital Partners

Manhattan, NY • On-site

Full-time

Posted 13 days ago


Job description

Roth Capital Partners, LLC is a relationship-driven investment bank focused on serving growth companies and their investors. In addition to capital markets and M&A advisory services, our full-service platform provides a variety of capital markets solutions, including high impact equity research, macroeconomic perspectives, institutional sales and trading, technical insights, derivatives strategies and corporate access. Headquartered in Newport Beach, California, Roth is a privately held, employee-owned organization and maintains offices throughout the U.S.
Roth is looking to add an Equity Research Associate to support a Senior Biotech Research Analyst focusing on emerging SMID-cap firms in healthcare, particularly brain disorders and rare indications. The Equity Research Associate is responsible for research, client support, data collection, and statistical studies on industries and individual companies and their securities. Through training and on-the-job experience, the Research Associate learns the techniques and develops the skills necessary to research and analyze investment securities and to prepare and present investment recommendations.
Responsibilities include (but are not limited to):
  • Conduct investment research by evaluating the pipeline potential of publicly-trading biotech companies.
  • Search, collect, consolidate, and interpret company and industry data.
  • Develop and maintain financial models, market monitoring systems, and databases.
  • Assist in the preparation of research reports, notes, and briefs.
  • Communicate and respond to internal and external requests.
  • Meet with management teams of issuers, conduct onsite visits, and attend industry conferences.
  • Provide administrative support as required.
  • Attain required securities licenses.
  • Other responsibilities as assigned.
Skills and Attributes:
  • Excellent analytical skills and understanding of (or willing to learn) relevant financial concepts.
  • Ability to express ideas effectively and fluently to clients and internal members.
  • Ability to write clearly and concisely with speed and precision.
  • Ability to work effectively with minimal direction under tight deadlines and multiple priorities while maintaining a keen attention to detail.
  • Self-motivated, organized, has strong attention to detail and is willing to work within a flexible schedule.
Qualifications:
  • A bachelor’s degree in physical or life sciences; prior research experience in CNS-related areas and/or advanced scientific degree (e.g., Ph.D. in basic or translational sciences) is a plus
  • Strong proficiency in MS Office, Excel, PowerPoint, AI, Internet search tools and software applications.
About the Team: The candidate will report to a Senior Biotech Research Analyst who received his Ph.D. in Medicinal Chemistry from The University of Illinois at Chicago and conducted several years of Postdoctoral research at leading institutions, including Northwestern University (14 peer-reviewed publications/industry articles and 1 patent). In addition, he has seven years of Biotech Equity Research experience covering a broad range of indications, therapeutic modalities and firm sizes. At Roth, he covers 15 companies with a focus on neurology, neurodegeneration, neuromuscular and rare indications.
Compensation:  
70,000 base + commensurate on experience
Annual discretionary bonus
 

Powered by JazzHR

qi08LlbhTI